imagem de perfil
Am I the only one who is a little relieved?

It was clear that the drug would come off the list. Now it has happened. Small price slide and that's it. One worry less
10
imagem de perfil
@Jakobi my thought 👍
1
imagem de perfil
1
imagem de perfil
@Jakobi As described above, I also see more stability as a result
1
imagem de perfil
@Jakobi Small price slide of 20%. Who cares.
imagem de perfil
@Jakobi mini price slide
@Jakobi More than 1/4 of the value lost. But keep on talking everything up 😂
1
imagem de perfil
@equity_expert_1695 Yes, 25% is a lot. For me, the drawdown was difficult to estimate because of the hype beforehand. After the price rise since the beginning of the year, it could have been an even bigger correction.
GLP 1 was not the investment case for me personally. My entry was before the shortage issue began.
1
imagem de perfil
@Jakobi I think it's good too. Now we will see what the company is made of. What I don't like is that the CEO is selling shares again immediately before this issue becomes public. I can understand it, but it doesn't make a good impression on private investors. The same goes for the fact that he doesn't allow comments on X. I would like to see more openness, integrity and honesty when entrusting someone with my money.